Haematological Malignancies

• Mutational profiling through exome sequencing along with MYD88 L265P analysis could facilitate the diagnosis of Vitreoretinal lymphoma
• Prognostic value of microRNA-21/ Ki-67 in non- Hodgkin`s lymphoma; NCI experience
• Poster Discussion – Haematological malignancies - Invited Discussant 1068PD and 1069PD
• Invited Discussant 1070PD
• Presentation by expert
• Discussion led by Chair
• Differential expression of various miRNAs in Pediatric Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
• Molecular profiling and prognostic significance of TP53 mutations in Diffuse Large B Cell Lymphoma: identifying a high-risk subgroup
• Detection of Double Protein Expression in Diffuse Large B Cell Lymphoma
• A Phase Ia/Ib trial of the anti-programmed death-ligand 1 (PD-L1) human monoclonal antibody (mAb), CS1001, in patients (pts) with advanced solid tu...
• Evolution of Myeloid-Derived Suppressor Cells and Objective Response Rate in Relapsed/Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL) patients...
• Indolent B-cell lymphomas
• Aggressive B-cell lymphomas
• T-cell lymphomas
• Molecular profiling, prognosis and present Guidelines for Relapsed/Refractory AML
• Recent results with FLT3 Inhibitors in FLT3-ITD positive Relapsed/Refractory AML and future development
• Are FLT3 Mutated AML a special entity?
• Making fatigue visible: Results of the Lymphoma Coalition 2018 survey
• Presentation of case/condition
• Haematology and immunophenotyping
• Imaging
• Molecular biology
• Innate and adaptive immunity in older patients
• Proffered Paper – Haematological malignancies & pediatric oncology - Invited Discussant 1065O and 1066O
• Interim Evaluation of a Targeted Radiotherapeutic, CLR 131, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (R/R DLBCL)

• « Previous
• 1
• 2
• ...
• 42
• Next »